Maravai LifeSciences Announces June 2021 Investor Conference Schedule

SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of June.

On June 1, 2021, Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the William Blair Annual Growth Stock Conference at 10:00 a.m. PT.

On June 2, 2021, Kevin Herde will participate in a fireside chat at the Jefferies Healthcare Conference at 11:00 a.m. PT.

On June 10, 2021, Carl Hull, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs Healthcare Conference at 11:10 a.m. PT.

A live webcast of the presentations will be available to all interested parties on the Maravai LifeSciences investor relations website at http://investors.maravai.com. An archived version of the webcast will be available a few hours following the completion of each event on the Maravai investor relations website.

About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis, bioprocess impurity detection and analysis, and protein labeling and detection to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.

For more information about Maravai LifeSciences, visit www.maravai.com.

Contact Information:
Media Contact: Sara Michelmore
MacDougall
+1 781-235-3060
maravai@macbiocom.com

Investor Contact: Deb Hart
Maravai LifeSciences
+ 1 858-988-5917
ir@maravai.com